Of note, the vast majority (15/20; 75%) of the HCC displaying increased SGK3 immunolabeling in the tumor part belonged to the group associated with poorer prognosis (HCCP), suggesting that SGK3 expression might contribute to HCC aggressiveness and survival, in agreement with a previous study [15]. The gene discussed is SGK3; the disease is hepatocellular carcinoma.